These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus. Pantoja P; Pérez-Guzmán EX; Rodríguez IV; White LJ; González O; Serrano C; Giavedoni L; Hodara V; Cruz L; Arana T; Martínez MI; Hassert MA; Brien JD; Pinto AK; de Silva A; Sariol CA Nat Commun; 2017 Jun; 8():15674. PubMed ID: 28643775 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous Coinfection of Macaques with Zika and Dengue Viruses Does not Enhance Acute Plasma Viremia but Leads to Activation of Monocyte Subsets and Biphasic Release of Pro-inflammatory Cytokines. Valiant WG; Mattapallil MJ; Higgs S; Huang YS; Vanlandingham DL; Lewis MG; Mattapallil JJ Sci Rep; 2019 May; 9(1):7877. PubMed ID: 31133721 [TBL] [Abstract][Full Text] [Related]
8. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity. Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880 [TBL] [Abstract][Full Text] [Related]
10. Primary infection with dengue or Zika virus does not affect the severity of heterologous secondary infection in macaques. Breitbach ME; Newman CM; Dudley DM; Stewart LM; Aliota MT; Koenig MR; Shepherd PM; Yamamoto K; Crooks CM; Young G; Semler MR; Weiler AM; Barry GL; Heimsath H; Mohr EL; Eichkoff J; Newton W; Peterson E; Schultz-Darken N; Permar SR; Dean H; Capuano S; Osorio JE; Friedrich TC; O'Connor DH PLoS Pathog; 2019 Aug; 15(8):e1007766. PubMed ID: 31369649 [TBL] [Abstract][Full Text] [Related]
11. Viral Load and Cytokine Response Profile Does Not Support Antibody-Dependent Enhancement in Dengue-Primed Zika Virus-Infected Patients. Terzian ACB; Schanoski AS; Mota MTO; da Silva RA; Estofolete CF; Colombo TE; Rahal P; Hanley KA; Vasilakis N; Kalil J; Nogueira ML Clin Infect Dis; 2017 Oct; 65(8):1260-1265. PubMed ID: 29017246 [TBL] [Abstract][Full Text] [Related]
12. Does prior dengue virus exposure worsen clinical outcomes of Zika virus infection? A systematic review, pooled analysis and lessons learned. Masel J; McCracken MK; Gleeson T; Morrison B; Rutherford G; Imrie A; Jarman RG; Koren M; Pollett S PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007060. PubMed ID: 30682026 [TBL] [Abstract][Full Text] [Related]
13. An epidemiological survey of the current status of Zika and the immune interaction between dengue and Zika infection in Southern Taiwan. Wang WH; Urbina AN; Wu CC; Lin CY; Thitithanyanont A; Assavalapsakul W; Lu PL; Chen YH; Wang SF Int J Infect Dis; 2020 Apr; 93():151-159. PubMed ID: 31982624 [TBL] [Abstract][Full Text] [Related]
14. Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors. Li M; Zhao L; Zhang C; Wang X; Hong W; Sun J; Liu R; Yu L; Wang J; Zhang F; Jin X PLoS One; 2018; 13(7):e0200478. PubMed ID: 30044839 [TBL] [Abstract][Full Text] [Related]
15. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases. Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505 [TBL] [Abstract][Full Text] [Related]
16. Antibody-Dependent Enhancement and Zika: Real Threat or Phantom Menace? Martín-Acebes MA; Saiz JC; Jiménez de Oya N Front Cell Infect Microbiol; 2018; 8():44. PubMed ID: 29497604 [No Abstract] [Full Text] [Related]
17. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice. Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279 [TBL] [Abstract][Full Text] [Related]
18. Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques. McCracken MK; Gromowski GD; Friberg HL; Lin X; Abbink P; De La Barrera R; Eckles KH; Garver LS; Boyd M; Jetton D; Barouch DH; Wise MC; Lewis BS; Currier JR; Modjarrad K; Milazzo M; Liu M; Mullins AB; Putnak JR; Michael NL; Jarman RG; Thomas SJ PLoS Pathog; 2017 Aug; 13(8):e1006487. PubMed ID: 28771605 [TBL] [Abstract][Full Text] [Related]
19. The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis. Langerak T; Mumtaz N; Tolk VI; van Gorp ECM; Martina BE; Rockx B; Koopmans MPG PLoS Pathog; 2019 Apr; 15(4):e1007640. PubMed ID: 30998804 [TBL] [Abstract][Full Text] [Related]
20. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design. Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]